<DOC>
	<DOCNO>NCT00147823</DOCNO>
	<brief_summary>This prospective randomized study compare Vitoss alone versus Vitoss bone marrow aspirate benign bone lesion .</brief_summary>
	<brief_title>Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow Bone Lesions</brief_title>
	<detailed_description>Bone graft obtain patient 's bone ( autogenous ) , usually around pelvis , currently consider gold standard bone graft material . It provide structural scaffold patient 's bone may grow ( osteoconduction ) , growth factor stimulate healing ( osteoinduction ) , primitive cell ( progenitor ) stimulate bone formation directly ( osteogenesis ) . It readily regain blood supply surround tissue ( revascularization ) incorporate recipient site . However , significant disadvantage use patient 's bone graft include complication bone take ( donor site morbidity ) , limited availability expense . For defect create scraping ( curettage ) non-cancerous ( benign ) bone lesion , structural scaffold ( osteoconduction ) generally consider minimal necessary role graft material must serve allow heal defect . Hence , human donor bone procure time death ( allograft ) synthetic bone filler use alternative patient 's bone ( autogenous bone graft ) . The question remain whether additional growth factor stimulate bone formation ( osteoinductive property ) and/or cell form bone directly ( osteogenic property ) facilitate heal defect add material patient 's bone graft source . In experience use synthetic bone graft substitute ultraporous beta-tricalcium phosphate ( TCP ) ( Vitoss , Orthovita , Inc. ) last 3 year , graft material , combine local blood alone , perform well clinically persist year longer radiographically case . Prolonged persistence graft material may serve potential stress riser , although observe untoward late effect publish work . Several author study effect composite graft form combination bone graft substitute patient 's bone marrow animal model promise result . There study current literature evaluate effect heal composite ultraporous beta-tricalcium phosphate bone marrow aspirate ( BMA ) defect scrap benign tumor ( cavitary defect ) human . The purpose study prospectively examine heal cavitary defect treat TCP alone versus treat TCP combine BMA . Our hypothesis graft resorption trabeculation ( radiographic measure incorporation synthetic material native bone ) advance time point patient receive BMA plus TCP compare receive TCP alone . Patients type benign bone lesion indicate surgical curettage would offer inclusion study follow minimum 2 year post-operatively . Bone marrow aspiration would obtain needle insert skin ( percutaneous aspiration ) large bone pelvis ( iliac crest ) use standard bone marrow aspiration needle . Patients infection , bone marrow disorder , condition preclude use supplementary patient 's bone marrow well prefer use bone graft material ( autograft ) donate human bone graft ( allograft ) alone would exclude . Each patient undergo radiographic evaluation lesion 6 week , 3 month , 6 month , 1 year , 18 month 2 year post operatively . At one time point ( 1 year ) computerize tomogram ( CT ) graft region obtain patient . Two qualify , blind , independent reviewer evaluate radiograph CT scan six criterion : 1. presence graft within soft tissue , 2. presence rim radiolucency surround graft defect , 3. size/circumference rim radiolucency , 4. resorption graft material , 5. trabeculation defect 6. persistence graft material lesion . Kappa statistic show good agreement parameter retrospective preliminary analysis result TCP use without bone marrow first 2 year use PI .</detailed_description>
	<mesh_term>Bone Diseases</mesh_term>
	<criteria>Patients benign bone lesion require surgical curettage Patients infection , bone marrow disorder , contraindication use supplemental bone marrow aspiration well prefer autologous allogeneic graft material alone ( without synthetic filler ) would exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Bone formation</keyword>
	<keyword>Bone lesion</keyword>
	<keyword>Benign bone lesion</keyword>
</DOC>